Genoray Co., Ltd. (KOSDAQ:122310)

Genoray Statistics

Total Valuation

Genoray has a market cap or net worth of KRW 56.74 billion. The enterprise value is 77.81 billion.

Market Cap	56.74B
Enterprise Value	77.81B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	Apr 2, 2025

Share Statistics

Genoray has 12.28 million shares outstanding. The number of shares has decreased by -6.11% in one year.

Current Share Class	12.28M
Shares Outstanding	12.28M
Shares Change (YoY)	-6.11%
Shares Change (QoQ)	-0.75%
Owned by Insiders (%)	32.48%
Owned by Institutions (%)	0.27%
Float	8.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.54
PB Ratio	0.72
P/TBV Ratio	0.72
P/FCF Ratio	13.86
P/OCF Ratio	6.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.44, with an EV/FCF ratio of 19.00.

EV / Earnings	-11.50
EV / Sales	0.74
EV / EBITDA	8.44
EV / EBIT	80.18
EV / FCF	19.00

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.45.

Current Ratio	2.00
Quick Ratio	0.68
Debt / Equity	0.45
Debt / EBITDA	3.84
Debt / FCF	8.64
Interest Coverage	0.84

Financial Efficiency

Return on equity (ROE) is -8.58% and return on invested capital (ROIC) is 0.51%.

Return on Equity (ROE)	-8.58%
Return on Assets (ROA)	0.47%
Return on Invested Capital (ROIC)	0.51%
Return on Capital Employed (ROCE)	1.09%
Revenue Per Employee	291.33M
Profits Per Employee	-18.79M
Employee Count	360
Asset Turnover	0.81
Inventory Turnover	1.44

Taxes

Income Tax	-3.48B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.51% in the last 52 weeks. The beta is 0.29, so Genoray's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-19.51%
50-Day Moving Average	4,983.30
200-Day Moving Average	5,467.08
Relative Strength Index (RSI)	34.35
Average Volume (20 Days)	16,702

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genoray had revenue of KRW 104.88 billion and -6.76 billion in losses. Loss per share was -529.33.

Revenue	104.88B
Gross Profit	38.91B
Operating Income	970.48M
Pretax Income	-10.97B
Net Income	-6.76B
EBITDA	9.22B
EBIT	970.48M
Loss Per Share	-529.33

Balance Sheet

The company has 13.61 billion in cash and 35.38 billion in debt, giving a net cash position of -21.77 billion or -1,772.63 per share.

Cash & Cash Equivalents	13.61B
Total Debt	35.38B
Net Cash	-21.77B
Net Cash Per Share	-1,772.63
Equity (Book Value)	78.97B
Book Value Per Share	6,486.99
Working Capital	37.53B

Cash Flow

In the last 12 months, operating cash flow was 8.30 billion and capital expenditures -4.20 billion, giving a free cash flow of 4.09 billion.

Operating Cash Flow	8.30B
Capital Expenditures	-4.20B
Free Cash Flow	4.09B
FCF Per Share	333.38

Margins

Gross margin is 37.10%, with operating and profit margins of 0.93% and -6.45%.

Gross Margin	37.10%
Operating Margin	0.93%
Pretax Margin	-10.46%
Profit Margin	-6.45%
EBITDA Margin	8.79%
EBIT Margin	0.93%
FCF Margin	3.90%

Dividends & Yields

This stock pays an annual dividend of 180.00, which amounts to a dividend yield of 3.81%.

Dividend Per Share	180.00
Dividend Yield	3.81%
Dividend Growth (YoY)	12.50%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	6.11%
Shareholder Yield	9.92%
Earnings Yield	-11.92%
FCF Yield	7.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 21, 2020. It was a forward split with a ratio of 3.

Last Split Date	Feb 21, 2020
Split Type	Forward
Split Ratio	3

Scores

Genoray has an Altman Z-Score of 3.03 and a Piotroski F-Score of 3.

Altman Z-Score	3.03
Piotroski F-Score	3